Mounjaro side effects: what the dual mechanism means for your stomach
Reviewed against published clinical trial data. Last updated August 2026.
Medically reviewed by Dr. Kaynat Khan, Endocrinology · Obesity Medicine
Quick answer
Mounjaro's common side effects (nausea, diarrhea, constipation) overlap heavily with other GLP-1 medicines, and some head-to-head data shows somewhat lower nausea than semaglutide at comparable points. Rare but serious risks include pancreatitis and gallbladder problems. Individual results vary.
Mounjaro works on two hormone pathways instead of one. People assume that means double the side effects. The data says something more specific than that.
Mounjaro's active ingredient, tirzepatide, acts on two hunger-hormone pathways, GLP-1 and GIP, instead of one. It is a fair guess that working on two systems means more side effects. The actual data is more specific than that guess.
What shows up, and how it compares
Nausea, diarrhea, constipation, and stomach discomfort are the most common, the same general list as other GLP-1 medicines. In some head-to-head trial data, Mounjaro has shown somewhat lower nausea rates than semaglutide at comparable points in treatment (SheMed, 2026), though individual results vary and this is not a guarantee for any one person.
Why "two hormones" is not automatically "double trouble"
The GIP pathway that makes Mounjaro different is not simply adding more of the same effect, it works alongside GLP-1 rather than stacking identical side effects on top of it. This is part of why the side-effect picture is not simply worse than single-pathway medicines, even though the weight-loss effect is often stronger.
Rare, but serious
Pancreatitis and gallbladder problems, including gallstones, are uncommon but real risks with tirzepatide, the same caution that applies across this drug class. Mounjaro is not for anyone with a personal or family history of medullary thyroid cancer or MEN 2.
A stronger average trial result is not the same as a worse tolerability profile. Both numbers matter, and neither one predicts exactly how your own body will respond.
If you are weighing Mounjaro against a semaglutide option specifically for tolerability, that is a real, reasonable question for your doctor, not something a trial average can answer for you personally.
Common questions
Does Mounjaro cause more side effects than Ozempic or Wegovy?
Not necessarily. Mounjaro's side-effect list overlaps heavily with semaglutide medicines, and some head-to-head data shows somewhat lower nausea rates, though results vary by individual.
Why does Mounjaro work on two hormones?
Tirzepatide acts on both GLP-1 and GIP pathways. This is linked to its often stronger weight-loss results in trials, but does not simply double the side-effect burden.
What are the serious risks of Mounjaro?
Pancreatitis and gallbladder problems, including gallstones, are uncommon but serious. It is also not for anyone with a personal or family history of medullary thyroid cancer.
Is Mounjaro easier on the stomach than Wegovy?
Some head-to-head data suggests somewhat lower nausea rates for Mounjaro at comparable points in treatment, but this varies by individual and is not guaranteed for everyone.
Do Mounjaro side effects improve over time?
For most people, yes. Side effects cluster around dose increases and tend to ease as the body adjusts, especially with a gradual dosing schedule.
Sources
This article is general information, not medical advice. A doctor decides what is right for you in a consultation.